Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review

por Huang, Min, Haiderali, Amin, Fox, Grace E., Frederickson, Andrew, Cortes, Javier, Fasching, Peter A., O’Shaughnessy, Joyce
Publicado 2022

Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis

por Cortes, Javier, Haiderali, Amin, Huang, Min, Pan, Wilbur, Schmid, Peter, Akers, Katherine G., Park, Julie E., Frederickson, Andrew M., Fasching, Peter A., O’Shaughnessy, Joyce
Publicado 2023

Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the Uni...

por Huang, Min, A. Fasching, Peter, Haiderali, Amin, Xue, Weiguang, Yang, Chelsey, Pan, Wilbur, Zhou, Zheng-Yi, Hu, Peter, Chaudhuri, Mitashri, Le Bailly De Tilleghem, Celine, Cappoen, Nicolas, O’Shaughnessy, Joyce
Publicado 2023